Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
Clinical trial NCT04184921 · COMPLETED
Trial details
- NCT number
- NCT04184921
- Sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2023-06-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.